Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...

Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...

A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting how tumor cells produce energy.

A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...

New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a personalized mRNA vaccine for pancreatic cancer at Memorial Sloan ...

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs that could offer rare hope to patients given this particularly deadly ...

PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer, today announced ...